Floatz logo

Dilaudid

Constipation Drug Induced

University of Illinois College of Medicine at PeoriaPhase 4 / ApprovedDormant
BB
65/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
50/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Constipation Drug Induced cohort.

Asset / SponsorPhaseRating
LIDOCAINE
University of Illinois College of Medicine at Peoria
Phase 4BB
(±)-2-(O-CHLOROPHENYL)-2-(METHYLAMINO)CYCLOHEXANONE
University of Illinois College of Medicine at Peoria
Phase 4BB
(±)-TRAMADOL
University of Illinois College of Medicine at Peoria
Phase 4BB
NEPENTHE
University of Illinois College of Medicine at Peoria
Phase 4BB
(±)-1-BUTYL-2',6'-PIPECOLOXYLIDIDE MONOHYDROCHLORIDE
University of Illinois College of Medicine at Peoria
Phase 4BB

View all 11 →

Same molecule, other indications

Dilaudid is also rated in:

Colon DiverticulosisDormant
BB
Indicative ·
65 / 100
View asset →
diverticulitis of colonDormant
BB
Indicative ·
65 / 100
View asset →
ileusDormant
BB
Indicative ·
65 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →